| Views | |
|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 244 |
| January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | |
|---|---|---|---|---|---|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 2 | 7 | 13 | 6 | 3 | 12 | 3 |
| Views | |
|---|---|
| SCOPUS19337213-2016-SID84975221908-a1.pdf | 32 |
| Views | |
|---|---|
| Russia | 78 |
| Views | |
|---|---|
| Kazan | 78 |